Polycystic Ovary Syndrome (PCOS) Treatment Global Strategic Research Report 2024-2030: North America and Europe Dominates, Asia-Pacific to Exhibit Fastest Growth [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
- Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Polycystic Ovary Syndrome (PCOS) Treatment Market to Reach $3.8 Billion by 2030 The global market for Polycystic Ovary Syndrome (PCOS) Treatment estimated at US$2.6 Billion in the year 2023, is projected to reach a revised size of US$3.8 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Recent market activities highlight a competitive landscape with players categorized as strong, active, niche, or trivial in 2023. Key market trends and drivers include the rising incidence of PCOS, advancements in PCOS management, and the growing prevalence of obesity, which is a significant risk factor for PCOS. These factors collectively spur the demand for PCOS drugs and drive market expansion. The global market for Polycystic Ovary Syndrome (PCOS) treatment is poised for steady growth, driven by rising awareness and the increasing incidence of PCOS. Insulin-Sen
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott (ABT) Stock Sinks As Market Gains: Here's Why [Yahoo! Finance]Yahoo! Finance
- In-vitro Colorectal Cancer Screening Tests Market to Reach Over US$ 2.5 Bn by 2034, Driven by a 7.1% CAGR | Transparency Market Research, Inc. [Yahoo! Finance]Yahoo! Finance
- Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories [Yahoo! Finance]Yahoo! Finance
- Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? [Yahoo! Finance]Yahoo! Finance
- MD+DI Names Babson Diagnostics, 2024 Medtech Company of the Year [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 10/16/24 - Beat
ABT
Sec Filings
- 11/15/24 - Form 8-K
- 11/4/24 - Form 144
- 10/31/24 - Form 10-Q
- ABT's page on the SEC website